AMSBIO
AMSBIO is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries.
Latest AMSBIO Content
Product News
Travel Grants for Cancer and Stem Cell Researchers
AMSBIO has launched a new 2024 travel grant award scheme for scientists under the age of thirty, employed in academia, research institutions, or companies engaged in cancer and stem cell research.
Product News
Custom Cryopreservation Storage Solutions for Cell Therapy Manufacturing
CELLBANKER® freezing media from AMSBIO is now available in customizable formats, seamlessly integrating into cell manufacturing processes with personalized formulations, volumes, and packaging.
Product News
High Performance Magnetic Beads for Immunoassays
AMSBIO has expanded its range of high-performance magnetic beads for use as detection labels in magnetic immunoassays or as a solid support phase in immunoassays.
Product News
AMSBIO Highlights Groundbreaking 2023 Life Science Research
In an informative new blog post - AMSBIO reflects on a selection of the groundbreaking life science and biomedical research undertaken by its customers during 2023.
Product News
Spatial Biology Multi-Omics Profiling Tools for Advanced Biomedical Research
AMSBIO announce the launch of a custom service providing access to a suite of powerful spatial biology multi-omics profiling tools.
Product News
Cost Effective Customizable ELISA Assay Kits
AMSBIO has announced a new range of customizable ELISA assay kits designed to enable experienced researchers to achieve reliable and reproducible assay results.
Product News
Modelling Enables Breakthroughs in Neuromuscular Disease Research
A team of scientists have developed a protocol for the fabrication of a 3D microfluidic neuromuscular platform that can be used to model Motor Neuron Diseases (MND’s).
Product News
Scalable Production of iPS Spheroid Culture
The new ABLE 3D Magnetic Stir and Disposable Bioreactor System from AMSBIO provides cost-effective, lab-scale production of induced pluripotent stem (iPS) cell spheroid culture.
Product News
Optimizing Smooth Muscle Cell Cryopreservation for Cardiovascular Research
AMSBIO, in collaboration with the University of Strathclyde (UK), announce the release of a poster that describes a comprehensive assessment of the effects of three different cryopreservation reagents.
Product News
Custom Monoclonal Antibody Reveals Promising HER2+ Breast Cancer Target
AMSBIO has supplied a custom monoclonal antibody (mAB) to researchers at the TU Dortmund** in Germany to unravel the role of EDI3 in breast cancer development.
Advertisement
